AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Historical Holders from Q1 2016 to Q3 2025

Symbol
AVNS on NYSE
Type / Class
Equity / Common Stock - $0.01 Par Value
Shares outstanding
46,382,189
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
44,941,298
Holdings value
$519,509,443
% of all portfolios
0%
Number of holders
266
Number of buys
129
Number of sells
-119
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14.8% $84,305,460 6,826,353 BlackRock, Inc. 31 Mar 2025
T. Rowe Price Investment Management, Inc. 10.2% +25% $54,487,048 +$11,050,221 4,713,494 +25% T. Rowe Price Investment Management, Inc. 30 Sep 2025
VANGUARD GROUP INC 7.38% -23% $39,595,474 -$12,018,724 3,425,214 -23% The Vanguard Group 30 Sep 2025
RGM Capital, LLC 6.5% $36,883,510 2,986,519 RGM Capital, LLC 31 Dec 2024
ARMISTICE CAPITAL, LLC 5.39% $28,900,000 2,500,000 Armistice Capital, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.1% $27,212,212 2,352,634 Dimensional Fund Advisors LP 30 Sep 2025

Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 44,941,298 $519,509,443 -$417,911 $11.56 266
2025 Q2 44,711,937 $547,287,477 +$14,185,298 $12.24 279
2025 Q1 43,396,946 $623,274,490 -$6,741,914 $14.33 275
2024 Q4 43,159,764 $687,053,030 -$348,352 $15.92 253
2024 Q3 42,887,071 $1,030,142,636 +$14,845,110 $24.03 257
2024 Q2 42,331,138 $843,184,184 -$19,844,468 $19.92 254
2024 Q1 43,394,488 $863,829,555 -$12,610,070 $19.91 255
2023 Q4 43,936,227 $986,177,329 +$6,301,621 $22.43 261
2023 Q3 43,653,986 $883,886,301 -$24,810,694 $20.22 251
2023 Q2 44,367,274 $1,134,245,375 +$6,577,133 $25.56 267
2023 Q1 43,807,927 $1,302,667,520 +$18,327,231 $29.74 278
2022 Q4 43,474,984 $1,176,504,936 +$5,615,427 $27.06 274
2022 Q3 43,372,951 $944,662,406 -$2,543,596 $21.78 218
2022 Q2 43,323,037 $1,184,314,252 -$13,685,481 $27.34 227
2022 Q1 43,970,678 $1,472,010,622 +$2,331,652 $33.5 252
2021 Q4 43,852,763 $1,519,830,657 +$2,873,575 $34.67 251
2021 Q3 43,701,330 $1,363,473,910 -$25,618,497 $31.2 229
2021 Q2 44,393,122 $1,614,401,834 +$1,417,948 $36.37 239
2021 Q1 44,092,800 $1,928,597,642 -$45,329,737 $43.74 251
2020 Q4 45,157,960 $2,071,803,289 -$25,305,709 $45.88 240
2020 Q3 45,956,879 $1,526,673,060 -$9,601,150 $33.22 230
2020 Q2 46,293,558 $1,360,488,473 +$21,246,989 $29.39 233
2020 Q1 45,529,610 $1,226,168,208 -$38,883,046 $26.93 219
2019 Q4 45,819,566 $1,543,944,370 +$20,782,780 $33.7 247
2019 Q3 45,225,869 $1,694,273,669 -$5,936,111 $37.46 250
2019 Q2 45,322,055 $1,976,386,420 +$18,591,188 $43.61 277
2019 Q1 45,113,689 $1,925,520,203 +$46,047,746 $42.68 296
2018 Q4 43,999,885 $1,970,607,092 -$23,436,579 $44.79 305
2018 Q3 42,817,781 $2,932,605,954 +$2,861,296,937 $68.5 350
2018 Q2 1,040,879 $59,567,007 +$59,548,000 $57.26 34
2018 Q1 332 $15,299 +$599 $46.08 2
2017 Q4 319 $14,732 $46.18 2
2017 Q3 319 $14,364 -$1,254 $45.03 2
2017 Q2 347 $13,630 $39.28 3
2017 Q1 347 $13,217 -$457 $38.08 3
2016 Q4 359 $13,276 -$2,737 $36.98 3
2016 Q3 432 $14,973 -$1,629 $34.66 2
2016 Q2 479 $15,577 -$6,000 $32.52 2
2016 Q1 611 $19,762 $28.73 3